Variant report

Variant	nsv541088
Chromosome Location	chr11:75870189-75922608
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1263)
CpG islands
(count:2446)
Chromatin interactive
region (count:87)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1263 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:75919860-75920108	HepG2	liver:	n/a	n/a
2	ATF2	chr11:75877385-75877776	GM12878	blood:	n/a	n/a
3	ATF2	chr11:75877442-75877843	GM12878	blood:	n/a	n/a
4	ATF3	chr11:75919853-75920215	A549	lung:	n/a	n/a
5	ATF3	chr11:75919783-75920220	A549	lung:	n/a	n/a
6	BACH1	chr11:75918583-75919316	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr11:75916750-75916926	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr11:75919833-75920847	H1-hESC	embryonic stem cell:	n/a	n/a
9	BACH1	chr11:75921380-75922316	H1-hESC	embryonic stem cell:	n/a	n/a
10	BACH1	chr11:75918709-75918900	K562	blood:	n/a	n/a
11	BATF	chr11:75877452-75877791	GM12878	blood:	n/a	n/a
12	BATF	chr11:75880537-75880793	GM12878	blood:	n/a	n/a
13	BATF	chr11:75877503-75877745	GM12878	blood:	n/a	n/a
14	BATF	chr11:75880507-75880811	GM12878	blood:	n/a	n/a
15	BCL11A	chr11:75877511-75877755	GM12878	blood:	n/a	chr11:75877743-75877752
16	BCL11A	chr11:75880481-75880847	GM12878	blood:	n/a	chr11:75880797-75880806
17	BCL11A	chr11:75877450-75877789	GM12878	blood:	n/a	chr11:75877743-75877752
18	BCL3	chr11:75919791-75920256	A549	lung:	n/a	chr11:75919827-75919836
19	BCL3	chr11:75918338-75918916	A549	lung:	n/a	chr11:75918813-75918822
20	BHLHE40	chr11:75917372-75917610	K562	blood:	n/a	chr11:75917535-75917551
21	BHLHE40	chr11:75895960-75896047	K562	blood:	n/a	n/a
22	BHLHE40	chr11:75917520-75917589	GM12878	blood:	n/a	chr11:75917535-75917551
23	BHLHE40	chr11:75918652-75918875	HepG2	liver:	n/a	n/a
24	BHLHE40	chr11:75879567-75879848	K562	blood:	n/a	n/a
25	BHLHE40	chr11:75918605-75918909	K562	blood:	n/a	n/a
26	BHLHE40	chr11:75874343-75874668	HepG2	liver:	n/a	chr11:75874506-75874515 chr11:75874499-75874520 chr11:75874505-75874514 chr11:75874505-75874514 chr11:75874504-75874513
27	BHLHE40	chr11:75874344-75874627	K562	blood:	n/a	chr11:75874506-75874515 chr11:75874499-75874520 chr11:75874505-75874514 chr11:75874505-75874514 chr11:75874504-75874513
28	BHLHE40	chr11:75919847-75920073	GM12878	blood:	n/a	n/a
29	BHLHE40	chr11:75880588-75880997	GM12878	blood:	n/a	n/a
30	BHLHE40	chr11:75877454-75877762	GM12878	blood:	n/a	n/a
31	BHLHE40	chr11:75918623-75918961	GM12878	blood:	n/a	n/a
32	BHLHE40	chr11:75874450-75874566	GM12878	blood:	n/a	chr11:75874506-75874515 chr11:75874499-75874520 chr11:75874505-75874514 chr11:75874505-75874514 chr11:75874504-75874513
33	BHLHE40	chr11:75921554-75922195	HepG2	liver:	n/a	chr11:75921944-75921960 chr11:75921941-75921957
34	BRCA1	chr11:75917362-75917369	Hela-S3	cervix:	n/a	n/a
35	BRCA1	chr11:75918536-75918947	Hela-S3	cervix:	n/a	n/a
36	BRCA1	chr11:75919889-75920503	Hela-S3	cervix:	n/a	n/a
37	CBX3	chr11:75918218-75918990	K562	blood:	n/a	n/a
38	CBX3	chr11:75873978-75874336	K562	blood:	n/a	n/a
39	CBX3	chr11:75917274-75917681	K562	blood:	n/a	n/a
40	CCNT2	chr11:75917343-75917789	K562	blood:	n/a	n/a
41	CCNT2	chr11:75895841-75896045	K562	blood:	n/a	n/a
42	CCNT2	chr11:75872492-75872651	K562	blood:	n/a	n/a
43	CCNT2	chr11:75918618-75918977	K562	blood:	n/a	chr11:75918965-75918974
44	CEBPB	chr11:75918279-75918452	K562	blood:	n/a	n/a
45	CEBPB	chr11:75917830-75918975	Hela-S3	cervix:	n/a	n/a
46	CEBPB	chr11:75918220-75919075	A549	lung:	n/a	n/a
47	CEBPB	chr11:75918338-75918535	HepG2	liver:	n/a	n/a
48	CEBPB	chr11:75918220-75918799	K562	blood:	n/a	n/a
49	CEBPB	chr11:75917020-75917495	Hela-S3	cervix:	n/a	n/a
50	CEBPB	chr11:75901486-75901900	IMR90	lung:	n/a	n/a

(count:2446 , 50 per page) page: 1 2 3 4 5 6 7 ... 49

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:75918089-75918139	SK-N-SH	brain:	n/a
2	chr11:75922323-75922373	CMK	blood:	n/a
3	chr11:75917844-75917894	Jurkat	blood:	n/a
4	chr11:75876419-75876469	HPAEpiC	pulmonary alveolar:	n/a
5	chr11:75879348-75879398	GM19239	blood:	n/a
6	chr11:75919130-75919180	ECC-1	luminal epithelium:	n/a
7	chr11:75918089-75918139	SK-N-SH	brain:	n/a
8	chr11:75922323-75922373	CMK	blood:	n/a
9	chr11:75917844-75917894	Jurkat	blood:	n/a
10	chr11:75876419-75876469	HPAEpiC	pulmonary alveolar:	n/a
11	chr11:75879348-75879398	GM19239	blood:	n/a
12	chr11:75919130-75919180	ECC-1	luminal epithelium:	n/a
13	chr11:75921940-75921990	MCF-7	breast:	n/a
14	chr11:75919862-75919912	PFSK-1	brain:	n/a
15	chr11:75917251-75917301	CMK	blood:	n/a
16	chr11:75922323-75922373	BE2_C	brain:	n/a
17	chr11:75922323-75922373	ovcar-3	ovarian:	n/a
18	chr11:75905917-75905967	HIPEpiC	eye:	n/a
19	chr11:75919130-75919180	T-47D	breast:	n/a
20	chr11:75920233-75920283	NHDF-neo	bronchial:	n/a
21	chr11:75921808-75921858	SKMC	muscle:	n/a
22	chr11:75917353-75917403	Jurkat	blood:	n/a
23	chr11:75922172-75922222	Caco-2	colon:	n/a
24	chr11:75918089-75918139	HCT-116	colon:	n/a
25	chr11:75898203-75898253	HEEpiC	esophagus:	n/a
26	chr11:75917251-75917301	HUVEC	blood vessel:	n/a
27	chr11:75916460-75916510	AoSMC	blood vessel:	n/a
28	chr11:75909015-75909065	HRE	kidney:	n/a
29	chr11:75922323-75922373	GM19239	blood:	n/a
30	chr11:75921808-75921858	NH-A	brain:	n/a
31	chr11:75878127-75878177	ProgFib	skin:	n/a
32	chr11:75876135-75876185	AG10803	skin:	n/a
33	chr11:75922172-75922222	K562	blood:	n/a
34	chr11:75878127-75878177	GM19239	blood:	n/a
35	chr11:75878127-75878177	AG04449	skin:	fetal
36	chr11:75921940-75921990	Hepatocyte	liver:	n/a
37	chr11:75876135-75876185	T-47D	breast:	n/a
38	chr11:75917844-75917894	HAEpiC	amniotic membrane:	n/a
39	chr11:75916460-75916510	HNPCEpiC	eye:	n/a
40	chr11:75916460-75916510	PrEC	prostate:	n/a
41	chr11:75922323-75922373	HEK293	kidney:	embryo
42	chr11:75873027-75873077	HUVEC	blood vessel:	n/a
43	chr11:75921808-75921858	AG04450	lung:	fetal
44	chr11:75905917-75905967	BE2_C	brain:	n/a
45	chr11:75921433-75921483	HAEpiC	amniotic membrane:	n/a
46	chr11:75922172-75922222	Jurkat	blood:	n/a
47	chr11:75905850-75905900	AG09309	skin:	n/a
48	chr11:75873027-75873077	SK-N-MC	brain:	n/a
49	chr11:75905850-75905900	HRCEpiC	kidney:	n/a
50	chr11:75921940-75921990	PrEC	prostate:	n/a

(count:87 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr11:75872410..75875308-chr11:75879381..75883436,3	K562	blood:
2	chr11:75888382..75891358-chr11:75893738..75896231,2	MCF-7	breast:
3	chr11:75886513..75888497-chr11:75907057..75909283,2	MCF-7	breast:
4	chr11:75918371..75919261-chr11:76391667..76392614,4	MCF-7	breast:
5	chr11:75895372..75898295-chr11:75906346..75908229,2	K562	blood:
6	chr11:75919700..75922037-chr11:76092044..76093720,2	MCF-7	breast:
7	chr11:75892849..75895480-chr11:75897932..75899434,2	K562	blood:
8	chr11:75907802..75910235-chr11:75912499..75914692,2	K562	blood:
9	chr11:75907463..75909415-chr11:75917684..75920104,2	MCF-7	breast:
10	chr11:75891012..75893171-chr11:75895940..75897806,2	K562	blood:
11	chr11:75877596..75879712-chr11:75888366..75889930,2	K562	blood:
12	chr11:75862934..75863810-chr11:75918354..75919268,2	K562	blood:
13	chr11:75898285..75900069-chr11:75902238..75904019,2	K562	blood:
14	chr11:75679088..75681419-chr11:75870768..75873220,2	K562	blood:
15	chr11:75918804..75919327-chr3:149116735..149117584,2	MCF-7	breast:
16	chr11:75908327..75910235-chr11:75911530..75913999,2	K562	blood:
17	chr11:75879470..75881382-chr11:75903439..75906024,2	MCF-7	breast:
18	chr11:75881616..75884148-chr11:75897760..75900480,2	MCF-7	breast:
19	chr1:156698046..156698801-chr11:75908969..75909469,2	Hela-S3	cervix:
20	chr11:75901629..75903680-chr11:75921082..75923446,2	K562	blood:
21	chr11:75888382..75891358-chr11:75893738..75896231,2	MCF-7	breast:
22	chr11:75915411..75918045-chr11:75920337..75923182,4	MCF-7	breast:
23	chr11:75872410..75875308-chr11:75879381..75883436,3	K562	blood:
24	chr11:75526830..75528448-chr11:75885826..75888721,2	K562	blood:
25	chr11:75907802..75910235-chr11:75912499..75914692,2	K562	blood:
26	chr11:75892849..75895480-chr11:75897932..75899434,2	K562	blood:
27	chr11:75864698..75867155-chr11:75871013..75872936,2	MCF-7	breast:
28	chr11:75874099..75876373-chr11:75881253..75883763,2	MCF-7	breast:
29	chr11:75919323..75921624-chr11:75923992..75926827,3	MCF-7	breast:
30	chr11:75607577..75608491-chr11:75919794..75920666,2	MCF-7	breast:
31	chr11:75918322..75919263-chr11:76029385..76030419,7	MCF-7	breast:
32	chr11:75895025..75897686-chr11:75910991..75913944,2	K562	blood:
33	chr11:75892849..75895759-chr11:75897789..75899434,2	K562	blood:
34	chr11:75901629..75903680-chr11:75921082..75923446,2	K562	blood:
35	chr11:75919537..75920594-chr11:76028825..76030444,6	MCF-7	breast:
36	chr11:75915411..75918045-chr11:75920337..75923182,4	MCF-7	breast:
37	chr11:75908679..75911274-chr11:75914998..75917762,2	K562	blood:
38	chr11:75864528..75867031-chr11:75871798..75873454,2	K562	blood:
39	chr11:75878808..75880535-chr11:75885544..75887523,2	K562	blood:
40	chr11:75913174..75915616-chr11:76090569..76092152,2	MCF-7	breast:
41	chr11:75887769..75890550-chr11:75903812..75906303,2	K562	blood:
42	chr11:75918665..75919393-chr11:76002890..76003539,3	MCF-7	breast:
43	chr11:75916539..75918756-chr11:75919573..75922083,2	MCF-7	breast:
44	chr11:75881616..75884148-chr11:75897760..75900480,2	MCF-7	breast:
45	chr11:75874099..75876373-chr11:75881253..75883763,2	MCF-7	breast:
46	chr11:75918273..75920931-chr11:75945404..75947823,5	MCF-7	breast:
47	chr11:75886513..75888497-chr11:75907057..75909283,2	MCF-7	breast:
48	chr11:75898285..75900069-chr11:75902238..75904019,2	K562	blood:
49	chr11:75891012..75893171-chr11:75895940..75897806,2	K562	blood:
50	chr11:75911614..75914237-chr11:75920875..75922850,2	MCF-7	breast:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-WNT11-1	chr11:75922000-75922293	ENSG00000255362
2	lnc-UVRAG-2	chr11:75905685-75906115	ENSG00000254933.1
3	lnc-UVRAG-2	chr11:75901769-75901950	ENSG00000254933.1
4	lnc-PRKRIR-3	chr11:75917466-75917542	NONHSAT023149
5	lnc-PRKRIR-3	chr11:75921391-75921774	NONHSAT023149

No data

Variant related genes	Relation type
WNT11	TF binding region
ENSG00000254933	TF binding region
WNT11	CpG island
ENSG00000254933	CpG island
ENSG00000085741	chromatin interactions
ENSG00000158636	chromatin interactions
ENSG00000254933	chromatin interactions
ENSG00000137492	chromatin interactions
ENSG00000179240	chromatin interactions
ENSG00000255135	chromatin interactions
ENSG00000143319	chromatin interactions
ENSG00000143303	chromatin interactions

Extended variants
information (count: 2324 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:2324 , 50 per page) page: 1 2 3 4 5 6 7 ... 47

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs563410614	chr11:75870197-75870198	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs544917122	chr11:75870217-75870218	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs144647864	chr11:75870228-75870229	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs77625437	chr11:75870237-75870238	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs559606593	chr11:75870247-75870248	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs572493944	chr11:75870255-75870256	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs191613291	chr11:75870264-75870265	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs116937409	chr11:75870288-75870289	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs140713110	chr11:75870306-75870307	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs537901776	chr11:75870321-75870322	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs75938555	chr11:75870345-75870346	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs550763160	chr11:75870372-75870373	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs567769177	chr11:75870381-75870382	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs143007112	chr11:75870395-75870396	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs553372175	chr11:75870398-75870399	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs74871671	chr11:75870403-75870404	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs34524972	chr11:75870514-75870515	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs11236633	chr11:75870515-75870516	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs11236634	chr11:75870527-75870528	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs111878378	chr11:75870528-75870529	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs543622717	chr11:75870532-75870533	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs563213695	chr11:75870534-75870535	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs573717230	chr11:75870568-75870569	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs542251631	chr11:75870590-75870591	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs558972968	chr11:75870601-75870602	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs375368031	chr11:75870626-75870627	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs112207816	chr11:75870636-75870637	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs10899165	chr11:75870637-75870638	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs530984386	chr11:75870688-75870689	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs551184367	chr11:75870689-75870690	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs567644487	chr11:75870692-75870693	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs536799789	chr11:75870697-75870698	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs674365	chr11:75870709-75870710	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs182500408	chr11:75870745-75870746	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs566830406	chr11:75870764-75870765	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs539047973	chr11:75870781-75870782	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs35646860	chr11:75870829-75870830	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs140000114	chr11:75870860-75870861	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs142884471	chr11:75870887-75870888	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs536826490	chr11:75870901-75870902	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs187249840	chr11:75870917-75870918	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs573654607	chr11:75870922-75870923	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs7928722	chr11:75870930-75870931	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs541210558	chr11:75870948-75870949	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs553342887	chr11:75870985-75870986	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs75282976	chr11:75871029-75871030	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs200639867	chr11:75871079-75871080	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs543066620	chr11:75871081-75871082	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs560127155	chr11:75871091-75871092	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs117473517	chr11:75871093-75871094	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Glioblastoma multiforme	21080181	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Melanoma	18172304	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
lymphocytic leukemia	21291569	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Breast cancer	16620391	CNVD
Multiple myeloma	17550852	CNVD
Neuroblastoma	18923191	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	16616336	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	17217626	CNVD
Cancer	22429812	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	21251322	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21482786	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	16608533	CNVD
Usher syndrome	18421352	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21240255	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:1496 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:75833400-75872800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
2	chr11:75864400-75871800	Weak transcription	Right Atrium	heart
3	chr11:75864600-75872600	Weak transcription	Fetal Intestine Large	intestine
4	chr11:75865000-75876000	Weak transcription	Spleen	Spleen
5	chr11:75865800-75870400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
6	chr11:75867800-75875200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
7	chr11:75868200-75870400	Bivalent Enhancer	Fetal Muscle Leg	muscle
8	chr11:75869200-75871600	Weak transcription	Skeletal Muscle Female	skeletal muscle
9	chr11:75869200-75874400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr11:75869400-75871600	Weak transcription	Fetal Heart	heart
11	chr11:75869400-75871600	Weak transcription	Skeletal Muscle Male	skeletal muscle
12	chr11:75869400-75872600	Weak transcription	Adipose Nuclei	Adipose
13	chr11:75869600-75870200	Weak transcription	Fetal Lung	lung
14	chr11:75869600-75872600	Enhancers	Pancreas	Pancrea
15	chr11:75869600-75873000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr11:75870000-75870200	Enhancers	Placenta	Placenta
17	chr11:75870000-75870400	Bivalent Enhancer	HepG2	liver
18	chr11:75870200-75870800	Enhancers	Fetal Lung	lung
19	chr11:75870200-75871800	Weak transcription	Placenta	Placenta
20	chr11:75870400-75870600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
21	chr11:75870400-75874400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
22	chr11:75870400-75874600	Enhancers	Fetal Muscle Leg	muscle
23	chr11:75870600-75873800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr11:75870800-75871400	Weak transcription	Fetal Lung	lung
25	chr11:75871000-75873600	Enhancers	Fetal Brain Male	brain
26	chr11:75871200-75871800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr11:75871200-75872000	Enhancers	Cortex derived primary cultured neurospheres	brain
28	chr11:75871200-75872600	Enhancers	Brain Germinal Matrix	brain
29	chr11:75871200-75872600	Enhancers	Fetal Brain Female	brain
30	chr11:75871400-75871800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr11:75871400-75873400	Enhancers	Fetal Lung	lung
32	chr11:75871600-75871800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
33	chr11:75871600-75872000	Bivalent Enhancer	HepG2	liver
34	chr11:75871600-75872600	Enhancers	Skeletal Muscle Male	skeletal muscle
35	chr11:75871600-75872600	Enhancers	Skeletal Muscle Female	skeletal muscle
36	chr11:75871600-75873800	Enhancers	Fetal Heart	heart
37	chr11:75871800-75872000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
38	chr11:75871800-75872400	Enhancers	Right Atrium	heart
39	chr11:75871800-75873000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
40	chr11:75871800-75874400	Enhancers	Placenta	Placenta
41	chr11:75872000-75872200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
42	chr11:75872000-75872400	Weak transcription	Cortex derived primary cultured neurospheres	brain
43	chr11:75872000-75872400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr11:75872000-75872400	Bivalent Enhancer	Fetal Stomach	stomach
45	chr11:75872000-75872400	Enhancers	Right Ventricle	heart
46	chr11:75872000-75872400	Enhancers	K562	blood
47	chr11:75872000-75872600	Bivalent/Poised TSS	HepG2	liver
48	chr11:75872000-75873800	Enhancers	Left Ventricle	heart
49	chr11:75872200-75873200	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr11:75872400-75872600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links